Chikungunya virus: New risk to transfusion safety in the Americas

Transfusion

Volumn 54, Issue 8, 2014, Pages 1911-1915

  Petersen, Lyle R ^a   Epstein, Jay S ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AEDES AEGYPTI; AEDES ALBOPICTUS; ARTHRALGIA; BLOOD; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; CHIKUNGUNYA ALPHAVIRUS; DENGUE; HIGH RISK PATIENT; HUMAN; MOSQUITO BITE; NUCLEIC ACID AMPLIFICATION; REVIEW; SAINT MARTIN; SOUTH AND CENTRAL AMERICA; TRANSFUSION MEDICINE; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; WESTERN HEMISPHERE;

ALPHAVIRUS INFECTIONS; BLOOD SAFETY; BLOOD TRANSFUSION; DISEASE OUTBREAKS; HUMANS;

EID: 84906074940     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12790     Document Type: Review

References (47)

1. Cassadou S, Boucau S, Petit-Sinturel M, et al. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 2014; 19: pii: 20752.
2. Leparc-Goffart I, Nougairede A, Cassadou S, et al. Chikungunya in the Americas. Lancet 2014; 383: 514.
3. Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet 2012; 379: 662-671.
4. Van Bortel W, Dorleans F, Rosine J, et al. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill 2014; 19: pii: 20759.
5. Chaves Tdo S, Pellini AC, Mascheretti M, et al. Travelers as sentinels for chikungunya fever, Brazil. Emerg Infect Dis 2012; 18: 529-530.
6. Powers AM, Logue CH,. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007; 88: 2363-2377.
7. Gibney KB, Fischer M, Prince HE, et al. Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis 2011; 52: e121-126.
8. Savini H, Gautret P, Gaudart J, et al. Travel-associated diseases, Indian Ocean Islands, 1997-2010. Emerg Infect Dis 2013; 19: 1297-1301.
9. Pan American Health Organization. Preparedness and response for chikungunya virus. Washington, D.C.: PAHO, 2011.
10. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 (Suppl 2): 1S-29S.
11. Atreya C, Nakhasi H, Mied P, et al. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion 2011; 51: 1855-1871.
12. Lanciotti RS, Kosoy OL, Laven JJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007; 13: 764-767.
13. Staikowsky F, Talarmin F, Grivard P, et al. Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PloS ONE 2009; 4: e7603.
14. Thiberville SD, Boisson V, Gaudart J, et al. Chikungunya fever: a clinical and virological investigation of outpatients on Réunion Island, South-West Indian Ocean. Plos Negl Trop Dis 2013; 7: e2004.
15. Panning M, Grywna K, van Esbroeck M, et al. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis 2008; 14: 416-422.
16. Renault P, Solet JL, Sissoko D, et al. A major epidemic of chikungunya virus infection on Réunion Island, France, 2005-2006. Am J Trop Med Hyg 2007; 77: 727-731.
17. Sergon K, Njuguna C, Kalani R, et al. Seroprevalence of chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 2008; 78: 333-337.
18. Krishnamoorthy K, Harichandrakumar KT, Krishna Kumari A, et al. Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. J Vector Borne Dis 2009; 46: 26-35.
19. Petersen LR, Busch MP,. Transfusion-transmitted arboviruses. Vox Sang 2010; 98: 495-503.
20. Porter KR, Beckett CG, Kosasih H, et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg 2005; 72: 60-66.
21. Rigau-Perez JG,. Surveillance for an emerging disease: dengue hemorrhagic fever in Puerto Rico, 1988-1997. P R Health Sci J 1999; 18: 337-345.
22. Rodriguez-Figueroa L, Rigau-Perez JG, Suarez EL, et al. Risk factors for dengue infection during an outbreak in Yanes, Puerto Rico in 1991. Am J Trop Med Hyg 1995; 52: 496-502.
23. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496: 504-507.
24. Eisen L, Moore CG,. Aedes (Stegomyia) aegypti in the continental United States: a vector at the cool margin of its geographic range. J Med Entomol 2013; 50: 467-478.
25. Brunkard JM, Robles Lopez JL, Ramirez J, et al. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 2007; 13: 1477-1483.
26. Ramos MM, Mohammed H, Zielinski-Gutierrez E, et al.; Dengue Serosurvey Working Group. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 2008; 78: 364-369.
27. Radke EG, Gregory CJ, Kintziger KW, et al. Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 2012; 18: 135-137.
28. Benedict MQ, Levine RS, Hawley WA, et al. Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector Borne Zoonotic Dis 2007; 7: 76-85.
29. Reiskind MH, Pesko K, Westbrook CJ, et al. Susceptibility of Florida mosquitoes to infection with chikungunya virus. Am J Trop Med Hyg 2008; 78: 422-425.
30. Lambrechts L,. Quantitative genetics of Aedes aegypti vector competence for dengue viruses: towards a new paradigm? Trends Parasitol 2011; 27: 111-114.
31. Tsetsarkin KA, Vanlandingham DL, McGee CE, et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. Plos Pathog 2007; 3: e201.
32. Lanciotti RS, Valadere AM,. Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis 2014;Aug. doi: 10.3201/eid2008.140268.
33. Vega-Rua A, Zouache K, Girod R, et al. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of chikungunya virus. J Virol 2014; 88: 6294-6306.
34. Appassakij H, Promwong C, Rujirojindakul P, et al. The risk of blood transfusion-associated Chikungunya fever during the 2009 epidemic in Songkhla Province, Thailand. Transfusion 2014; 54: 1945-1952.
35. Biggerstaff BJ, Petersen LR,. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-1026.
36. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-1017.
37. Brouard C, Bernillon P, Quatresous I, et al. Estimated risk of chikungunya viremic blood donation during an epidemic on Réunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008; 48: 1333-1341.
38. Rezza G, Nicoletti L, Angelini R, et al.; CHIKV Study Group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 1840-1846.
39. Liumbruno GM, Calteri D, Petropulacos K, et al. The chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008; 6: 199-210.
40. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198: 984-993.
41. Centers for Disease Control and Prevention. West Nile virus transmission through blood transfusion-South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007; 56: 76-79.
42. Centers for Disease Control and Prevention. Fatal West Nile virus infection after probable transfusion-associated transmission-Colorado, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 622-624.
43. Sissoko D, Moendandze A, Malvy D, et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PloS ONE 2008; 3: e3066.
44. Queyriaux B, Simon F, Grandadam M, et al. Clinical burden of chikungunya virus infection. Lancet Infect Dis 2008; 8: 2-3.
45. Economopoulou A, Dominguez M, Helynck B, et al. Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect 2009; 137: 534-541.
46. Rasongles P, Angelini-Tibert MF, Simon P, et al. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a chikungunya virus epidemic in Ile de La Réunion. Transfusion 2009; 49: 1083-1091.
47. Lieshout-Krikke RW, Zaaijer HL, Prinsze FJ,. The yield of temporary exclusion of blood donors, exposed to emerging infections abroad. Vox Sang 2013; 104: 12-18.